Skip to content
Medical AI ReportIndependent evaluations

1 shared rubric · Updated September 2026

Nabla vs Suki

Nabla and Suki share one scored category, AI medical scribes. Nabla scores higher in the shared category — 38–33 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

Reviewed by Abishek Shahi, MD · Last reviewed September 2026

Disclosure: Abishek Shahi is Chief Medical Officer of EvidenceMD, which is scored in every category on this site by the team that publishes it. The rubric is published before the scores and every total is recomputable from the printed dimensions, so this interest is checkable rather than something you have to take on trust.

Nabla

Scribes

38/50

Full Nabla review

Suki

Scribes

33/50

Full Suki review

Side by side

Nabla and Suki, dimension by dimension

Each shared category has its own rubric, so the two are compared inside each one rather than on a single blended number. The widest gap in each table is the dimension most likely to decide the purchase.

AI medical scribes

38 – 33Nabla by 5

AI medical scribes rubric, ordered by the size of the gap. Each dimension is scored out of 10.
DimensionNablaSukiGap
Access & pricePublished pricing, free tier, credential and regional eligibility, language coverage, and whether one clinician can evaluate the product without entering a sales process.74+3
Clinical reasoningWhether the product reasons about the encounter or only records it: ranked differential, problem-based assessment and plan, red-flag detection, and whether that reasoning is auditable rather than opaque.75+2
Documentation integrityICD-10 specificity, MEAT support, HCC recapture, E/M leveling and denial-risk checks — and whether each suggestion traces to verbatim text in the note so it survives an audit.78-1
Workflow & templatesTemplate depth and per-clinician customization, breadth of note types and specialties, non-physician coverage, and whether the tool can work on a note it did not draft.87+1
EHR & deploymentIntegration depth — native embed, authenticated API write-back, browser extension or copy-paste — plus enterprise rollout support and the procurement path.99—

Nabla

Best for
Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth.
Limitation
Customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.
Price
Free entry tier; paid from about $119/month

Suki

Best for
Health systems on Epic, Oracle Health, athenahealth or MEDITECH that need HCC-aware coding written straight into EHR fields rather than parked in a tab, plus the best-documented multilingual capture in the category at 80+ languages with published language IDs.
Limitation
No published price, no trial and no self-serve path, so an individual clinician cannot evaluate it at all. KLAS's own listing marks it limited market share on 18 organisations — too few live customers to qualify for the ranking Abridge has won twice — against Suki's claim of 400+ systems and partners.
Price
Not published; sales-led. The pricing page returns a 404.

The decision

Which one should you buy?

Choose Nabla when

  • Scribes

    Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth.

What it cannot do

Customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.

Every Nabla score

Choose Suki when

  • Scribes

    Health systems on Epic, Oracle Health, athenahealth or MEDITECH that need HCC-aware coding written straight into EHR fields rather than parked in a tab, plus the best-documented multilingual capture in the category at 80+ languages with published language IDs.

What it cannot do

No published price, no trial and no self-serve path, so an individual clinician cannot evaluate it at all. KLAS's own listing marks it limited market share on 18 organisations — too few live customers to qualify for the ranking Abridge has won twice — against Suki's claim of 400+ systems and partners.

Every Suki score

Limits

What this comparison cannot tell you

Neither tool has been benchmarked here against live patient data. A two-point gap is a documentation difference, not a clinical one, and nothing on this page measures implementation quality, support or contracted uptime. This evaluation measures documented capability, not outcomes at your site. Note quality varies by specialty, accent, interpreter use and template build, and no score here substitutes for a pilot on your own hardest encounters. Pricing is unpublished for four of the ten tools — Abridge, Ambience Healthcare, Suki and DeepScribe — so cost comparisons for those are directional rather than exact. Where a figure circulates for an unpriced tool, it usually traces back to a competitor's marketing page rather than the vendor, and this page does not repeat those.

Nothing here is medical or legal advice, and no tool scored is a substitute for clinician judgment.

Common questions

Nabla vs Suki: common questions

Is Nabla or Suki better?

Nabla and Suki share one scored category, AI medical scribes. Nabla scores higher in the shared category — 38–33 for AI medical scribes out of 50. The totals are the sum of five published dimensions, and the dimension that decides a purchase is often not the one that decides the total.

What is the biggest difference between Nabla and Suki?

For AI medical scribes the widest gap is access & price: 7/10 for Nabla against 4/10 for Suki. That dimension measures published pricing, free tier, credential and regional eligibility, language coverage, and whether one clinician can evaluate the product without entering a sales process.

When should you choose Nabla over Suki?

Nabla scores higher for AI medical scribes. Ambulatory groups where language coverage, breadth of EHR support and a published price matter more than inpatient coding depth. The case against it: customization is thinner than the enterprise tools at comparable cost, and some users report missed clinical detail on complex encounters.

When should you choose Suki over Nabla?

Health systems on Epic, Oracle Health, athenahealth or MEDITECH that need HCC-aware coding written straight into EHR fields rather than parked in a tab, plus the best-documented multilingual capture in the category at 80+ languages with published language IDs. The case against it: no published price, no trial and no self-serve path, so an individual clinician cannot evaluate it at all. KLAS's own listing marks it limited market share on 18 organisations — too few live customers to qualify for the ranking Abridge has won twice — against Suki's claim of 400+ systems and partners.

How do Nabla and Suki compare on price?

Nabla: Free entry tier; paid from about $119/month Suki: Not published; sales-led. The pricing page returns a 404. Pricing comes from each vendor's published pricing page; where a vendor publishes no rate, that is recorded rather than estimated.

Keep reading

The full rankings behind this comparison